Hepatic manifestations of tuberous sclerosis complex: A genotypic and phenotypic analysis

Clinical Genetics

Volumn 82, Issue 6, 2012, Pages 552-557

  Black, M E ^a   Hedgire, S S ^a   Camposano, S ^a   Paul, E ^a   Harisinghani, M ^a   Thiele, E A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Angiomyolipoma; Cysts; Hepatic masses; MTORC1; Sirolimus; Tuberous sclerosis

Indexed keywords

TUBERIN;

ADOLESCENT; ADULT; AGED; ANGIOMYOLIPOMA; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; CYST; DISEASE COURSE; FEMALE; GENETIC ANALYSIS; GENOTYPE; HUMAN; INFANT; KIDNEY DISEASE; LIVER HEMANGIOMA; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PHENOTYPE; PRESCHOOL CHILD; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; TUBEROUS SCLEROSIS;

ADOLESCENT; ADULT; AGE FACTORS; ANGIOMYOLIPOMA; CHILD; FEMALE; GENOTYPE; HUMANS; LIVER; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PREVALENCE; REGRESSION ANALYSIS; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TUBEROUS SCLEROSIS; TUMOR SUPPRESSOR PROTEINS;

EID: 84869088245     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/j.1399-0004.2012.01845.x     Document Type: Article

References (23)

1. European Chromosome 16 Tuberous Sclerosis Consortium. Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993: 75 (7): 1305-1315.
2. Slegtenhorst MV, de Hoogt R, Hermans C et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997: 277 (5327): 805-808.
3. Orlova KA, Crino PB. The tuberous sclerosis complex. Ann N Y Acad Sci 2010: 1184: 87-105.
4. Cook JA, Oliver K, Mueller RF, Sampson J. A cross sectional study of renal involvement in tuberous sclerosis. J Med Genet 1996: 33 (6): 480-484.
5. O'Callaghan FJ, Noakes MJ, Martyn CN, Osborne JB. An epidemiological study of renal pathology in tuberous sclerosis complex. BJU Int 2004: 94 (6): 853-857.
6. Rakowski SK, Winterkorn EB, Paul E, Steele DJ, Halpern EF, Thiele EA. Renal manifestations of tuberous sclerosis complex: incidence, prognosis, and predictive factors. Kidney Int 2006: 70 (10): 1777-1782.
7. Nelson CP, Sanda MG. Contemporary diagnosis and management of renal angiomyolipoma. J Urol 2002: 168 (4 Pt 1): 1315-1325.
8. Ryu JH, Moss J, Beck GJ et al. The NHLBI lymphangioleiomyomatosis registry: characteristics of 230 patients at enrollment. Am J Respir Crit Care Med 2006: 173 (1): 105-111.
9. Roach ES, DiMario FJ, Kandt RS, Northrup H. Tuberous sclerosis consensus conference: recommendations for diagnostic evaluation. J Child Neurol 1999: 14 (6): 401-407.
10. Dabora SL, Jozwiak S, Franz DN et al. Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs. Am J Hum Genet 2001: 68 (1): 64-80.
11. Fleury P, Smits N, van Baal S. The incidence of hepatic hamartomas in tuberous sclerosis. Evaluation by ultrasonography. Rofo 1987: 146 (6): 694-696.
12. Jozwiak S, Pedich M, Rajszys P, Michalowicz R. Incidence of hepatic hamartomas in tuberous sclerosis. Arch Dis Child 1992: 67 (11): 1363-1365.
13. Fricke BL, Donnelly LF, Casper KA, Bissler JJ. Frequency and imaging appearance of hepatic angiomyolipomas in pediatric and adult patients with tuberous sclerosis. Am J Roentgenol 2004: 182 (4): 1027-1030.
14. Dabora SL, Franz DN, Ashwal S et al. Multicenter phase 2 trial of sirolimus for tuberous sclerosis: kidney angiomyolipomas and other tumors regress and VEGF- D levels decrease. PLoS One 2011: 6: e23379.
15. Eisenhauer EA, Therasse P, Bogaerts J et al. New response evaluation criteria in solid tumours: revised RECIST Guideline (version 1.1). Eur J Cancer 2009: 45: 228-247.
16. Sancak O, Nellist M, Goedbloed M et al. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in Tuberous Sclerosis Complex. Eur J Hum Genet 2005: 13 (6): 731-741.
17. Au KS, Williams AT, Roach ES et al. Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States. Genet Med 2007: 9 (2): 88-100.
18. Camposano SE, Greenberg E, Kwiatkowski DJ, Thiele EA. Distinct clinical characteristics of tuberous sclerosis complex patients with no mutation identified. Ann Hum Genet 2009: 73 (2): 141-146.
19. Qin W, Kozlowski P, Taillon B et al. Ultra deep sequencing detects a low rate of mosaic mutations in tuberous sclerosis complex. Hum Genet 2010: 127 (5): 573-582.
20. Irie H, Honda H, Kuroiwa T et al. Hepatic angiomyolipoma: report of changing size and internal composition on follow-up examination in two cases. J Comput Assist Tomogr 1999: 23 (2): 310-313.
21. Huber C, Treutner KH, Steinau G, Schumpelick V. Ruptured hepatic angiolipoma in tuberous sclerosis complex. Langenbecks Arch Chir 1996: 381: 7-9.
22. Bissler JJ, McCormack FX, Young LR et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med 2008: 358 (2): 140-151.
23. Astrinidis A, Petri Henske E. Aberrant cellular differentiation and migration in renal and pulmonary tuberous sclerosis complex. J Child Neurol 2004: 19 (9): 710-715.